https://www.radcliffeckm.com/video-index/easd-24-kidney-cardiovascular-mortality-metabolic-and-safety-results-flow-trial 2024-09-12T10:51:17+01:00 0.5 https://www.radcliffeckm.com/video-index/easd-24-finearts-hf-diabetes-status-analysis 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/easd-24-semaglutide-pts-impaired-kidney-function-select-prespecified-analysis 2024-09-30T08:05:48+01:00 0.5 https://www.radcliffeckm.com/video-index/hfsa-24-hu6-patients-obesity-and-hfpef-humain-trial 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/hfsa-24-step-hfpef-exercise-function-and-frailty-status 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/aha-24-select-semaglutide-obese-and-overweight-patients-history-coronary-artery-bypass 2024-11-28T08:06:16+00:00 0.5 https://www.radcliffeckm.com/video-index/aha-24-late-breaking-discussion-flow-benefits-semaglutide-ckd-cardiovascular-status-or 2024-11-27T13:46:20+00:00 0.5 https://www.radcliffeckm.com/video-index/aha-24-late-breaking-discussion-summit-tirzepatide-patients-hfpef-and-obesity 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/empa-kidney-long-term-effects-empagliflozin-patients-chronic-kidney-disease 2024-12-04T07:53:42+00:00 0.5 https://www.radcliffeckm.com/video-index/simplifying-guidelines-cardio-kidney-metabolic-disease-expert-insights-dr-faiez-zannad 2025-12-04T07:44:18+00:00 0.5 https://www.radcliffeckm.com/video-index/time-restricted-eating-clinical-insights-metabolic-syndrome-management 2025-12-04T07:58:07+00:00 0.5 https://www.radcliffeckm.com/video-index/tht-2025-summit-impact-obesity-severity-tirzepatide-hfpef 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/integrating-new-weight-management-therapies-comprehensive-cvd-care 2025-03-25T10:59:01+00:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-1-multidisciplinary-implementation-strategies 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/keynote-session-kdigo-guideline-updates-2024 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-2-guideline-directed-therapy-crm-disease-evidence-base 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-3-managing-patients-crm-who-gets-what-when-and-why 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-4-weight-homeostasis-management-crm-disease-organised-support-charite 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-5-crm-disease-epidemiology-and-pathophysiology 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-6-anaemia-and-iron-deficiency 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/practical-implementation-non-steroidal-mineralocorticoid-receptor-antagonists-reduce 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-7-clinical-presentations-and-treatment-across-patient-journey-focus-ckd 2025-02-19T08:59:24+00:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-8-early-intervention-and-intensive-management 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/effects-glp-1ra-kidney-outcomes-ckd-and-t2d 2025-02-19T08:59:22+00:00 0.5 https://www.radcliffeckm.com/video-index/plenary-session-9-precision-medicine-crm 2025-02-19T08:59:22+00:00 0.5 https://www.radcliffeckm.com/video-index/session-1-obesity-disease-diagnosis-and-cardiovascular-disease-risk 2025-02-19T08:59:21+00:00 0.5 https://www.radcliffeckm.com/video-index/session-2-rapid-fire-sessions-challenges-treating-specific-cv-disease-patients-obesity 2025-02-19T08:59:20+00:00 0.5 https://www.radcliffeckm.com/video-index/session-3-healthful-nutrition-physical-activity-behaviour-modification-and-mdt 2025-02-19T08:59:19+00:00 0.5 https://www.radcliffeckm.com/video-index/session-4-medical-and-procedural-options-and-referral-pathways 2025-02-19T08:59:19+00:00 0.5 https://www.radcliffeckm.com/video-index/redefining-obesity-beyond-bmi 2025-03-25T10:58:43+00:00 0.5 https://www.radcliffeckm.com/video-index/acc-2025-lifetime-benefit-control-modifiable-risk-factors 2025-04-23T09:43:36+01:00 0.5 https://www.radcliffeckm.com/video-index/acc-2025-alpaca-phase-2-lepodisiran-extended-duration-small-interfering-rna-targeting 2025-04-23T10:10:43+01:00 0.5 https://www.radcliffeckm.com/video-index/acc-25-late-breaking-discussion-advance-htn-lorundrostat-patients-uncontrolled 2025-03-31T11:44:30+01:00 0.5 https://www.radcliffeckm.com/video-index/tirzepatide-shows-kidney-benefits-t2d-surpass-trials-analysis 2025-03-25T10:58:24+00:00 0.5 https://www.radcliffeckm.com/video-index/acc-25-late-breaking-discussion-stride-semaglutide-functional-capacity-patients-t2d-and 2025-03-31T11:46:10+01:00 0.5 https://www.radcliffeckm.com/video-index/acc-25-late-breaking-discussion-soul-semaglutide-patients-t2d 2025-04-08T09:28:40+01:00 0.5 https://www.radcliffeckm.com/video-index/reduce-it-cv-outcomes-icosapent-ethyl-baseline-ldl-c 2025-03-19T08:14:03+00:00 0.5 https://www.radcliffeckm.com/video-index/reduced-risk-cvd-after-bariatric-surgery-using-prevent-equations 2025-04-15T08:52:51+01:00 0.5 https://www.radcliffeckm.com/video-index/hrs-25-transform-af-glp-1-ras-secondary-prevention-af 2025-06-02T15:37:09+01:00 0.5 https://www.radcliffeckm.com/video-index/esc-hf-25-praise-hfref-glucagon-peptide-1-receptor-agonism-hfref-and-obesity 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/esc-hf-25-five-star-impact-finerenone-vascular-stiffness-and-cardiorenal-biomarkers-t2d 2025-05-28T14:19:35+01:00 0.5 https://www.radcliffeckm.com/video-index/esc-hf-25-kidney-function-trajectories-and-after-hf-hospitalisation-hfref 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/esc-hf-25-liver-stiffness-assess-central-venous-pressure-hf-or-low-ejection-fraction 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/esc-hfa-25-finearts-hf-trade-risk-and-benefit-finerenone-across-spectrum-kidney 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/eco-25-reset-trial-early-weight-loss-oral-shape-shifting-superabsorbent-hydrogel 2025-05-13T07:52:46+01:00 0.5 https://www.radcliffeckm.com/video-index/eco-25-surmount-1-weight-loss-trajectories-tirzepatide-obesity-or-overweight-patients 2025-05-15T08:46:49+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-acute-egfr-dips-and-disease-severity-effects-empagliflozin-kidney-outcomes 2025-06-20T13:16:14+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-impact-diabetes-albuminuria-egfr-dip-and-disease-severity-empagliflozin 2025-06-20T13:09:54+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-real-world-data-cv-and-renal-outcomes-diabetic-kidney-disease 2025-06-24T15:05:12+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-guideline-based-management-ckd-and-associated-risk-cardio-renal-outcomes 2025-06-20T13:04:14+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-exploring-margins-survival-benefit-deceased-donor-kidney-transplantation 2025-06-25T10:25:34+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-highlights-dr-kywe-kywe-soe 2025-06-20T13:00:59+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-treating-obesity-2025-and-beyond 2025-06-24T16:22:51+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-switching-steroidal-mineralocorticoid-receptor-antagonists-finerenone-patients 2025-06-20T12:58:45+01:00 0.5 https://www.radcliffeckm.com/video-index/era-25-highlights-dr-johannes-stegbauer 2025-06-25T10:00:37+01:00 0.5 https://www.radcliffeckm.com/video-index/era-2025-highlights-and-expert-perspectives-shifting-paradigm-igan-and-fsgs 2025-08-01T15:58:54+01:00 0.5 https://www.radcliffeckm.com/video-index/ecr-guest-editor-prof-chim-lang-his-upcoming-collection-obesity-focus-implications 2025-06-18T08:50:26+01:00 0.5 https://www.radcliffeckm.com/video-index/aer-article-spotlight-dr-win-his-new-publication-obesity-management-af-ablation 2025-06-18T08:50:25+01:00 0.5 https://www.radcliffeckm.com/video-index/cfr-article-spotlight-dr-el-sheikh-his-new-publication-obesity-nutrition-mortality 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/ada-25-clinical-implications-stride-study-endocrinologists 2025-07-10T11:30:08+01:00 0.5 https://www.radcliffeckm.com/video-index/ada-25-maritide-treatment-obesity-patients-or-without-type-2-diabetes 2025-07-10T12:00:21+01:00 0.5 https://www.radcliffeckm.com/video-index/ada-25-catalyst-trial-treatment-hypercortisolism-patients-type-2-diabetes 2025-07-02T07:57:54+01:00 0.5 https://www.radcliffeckm.com/video-index/ada-25-pathweigh-weight-management-primary-care 2025-07-10T15:45:27+01:00 0.5 https://www.radcliffeckm.com/video-index/aclm-clinical-practice-guideline-lifestyle-interventions-treatment-and-remission-t2d 2025-06-27T08:23:36+01:00 0.5 https://www.radcliffeckm.com/video-index/essence-semaglutide-patients-metabolic-dysfunction-associated-steatohepatitis 2025-06-30T08:51:24+01:00 0.5 https://www.radcliffeckm.com/video-index/ada-25-efficacy-and-safety-cagrisema-redefine-1-and-2 2025-07-10T12:40:53+01:00 0.5 https://www.radcliffeckm.com/video-index/managing-obesity-patients-heart-failure-2025-acc-scientific-statement 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/esc-25-lipoascreen-cascade-screening-elevated-lipoproteina 2025-09-05T08:11:16+01:00 0.5 https://www.radcliffeckm.com/video-index/esc-25-stride-outcomes-sex 2025-10-03T10:30:14+01:00 0.5 https://www.radcliffeckm.com/video-index/esc-congress-25-sema-vr-cardiolink-15-trial 2025-10-03T10:54:30+01:00 0.5 https://www.radcliffeckm.com/video-index/easd-2025-semaglutide-and-risk-reduction-major-adverse-limb-events-diabetes 2025-09-19T08:26:16+01:00 0.5 https://www.radcliffeckm.com/video-index/easd-25-empire-prevent-metabolic-effects-empagliflozin-patients-risk-heart-failure 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/easd-25-prespecified-analysis-confidence-simultaneous-finerenone-and-empagliflozin 2025-10-01T08:14:44+01:00 0.5 https://www.radcliffeckm.com/video-index/hfsa-25-sex-specific-outcomes-tirzepatide-obesity-related-hfpef-summit-trial 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/aha-25-lpa-and-ascvd-translating-causal-evidence-clinical-practice 2025-12-16T16:15:58+00:00 0.5 https://www.radcliffeckm.com/video-index/aha-25-pregnancy-and-ckm-health-essential-knowledge-cardiologists 2025-12-16T15:53:20+00:00 0.5 https://www.radcliffeckm.com/video-index/aha-2025-tirzsema-cvot-cardiovascular-outcomes-semaglutide-and-tirzepatide-clinical 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/aha-25-coralreef-hefh-oral-pcsk9-inhibitor-familial-hypercholesterolemia 2025-12-04T11:35:40+00:00 0.5 https://www.radcliffeckm.com/video-index/acc-26-momentum-prevalence-endogenous-hypercortisolism-resistant-hypertension 2026-03-30T08:18:38+01:00 0.5 https://www.radcliffeckm.com/video-index/acc-26-coralreef-durability-enlicitide-lipid-lowering-hypercholesterolaemia 2026-04-09T11:51:20+01:00 0.5 https://www.radcliffeckm.com/video-index/acc-26-surpass-cvot-tirzepatide-versus-dulaglutide-cardiorenal-outcomes-type-2-diabetes 2026-04-02T06:00:45+01:00 0.5 https://www.radcliffeckm.com/video-index/acc-2026-top-takeaways-2026-dyslipidaemia-guidelines 2026-04-03T08:01:22+01:00 0.5